SpringWorks Therapeutics Performance
| SWTXDelisted Stock | USD 46.99 0.00 0.00% |
The entity has a beta of 0.42, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, SpringWorks Therapeutics' returns are expected to increase less than the market. However, during the bear market, the loss of holding SpringWorks Therapeutics is expected to be smaller as well. SpringWorks Therapeutics right now has a risk of 0.0%. Please validate SpringWorks Therapeutics maximum drawdown, skewness, market facilitation index, as well as the relationship between the downside variance and rate of daily change , to decide if SpringWorks Therapeutics will be following its existing price patterns.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days SpringWorks Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, SpringWorks Therapeutics is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors. ...more
SpringWorks |
SpringWorks Therapeutics Relative Risk vs. Return Landscape
If you would invest 4,699 in SpringWorks Therapeutics on November 9, 2025 and sell it today you would earn a total of 0.00 from holding SpringWorks Therapeutics or generate 0.0% return on investment over 90 days. SpringWorks Therapeutics is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than SpringWorks, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
SpringWorks Therapeutics Target Price Odds to finish over Current Price
The tendency of SpringWorks Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 46.99 | 90 days | 46.99 | about 25.75 |
Based on a normal probability distribution, the odds of SpringWorks Therapeutics to move above the current price in 90 days from now is about 25.75 (This SpringWorks Therapeutics probability density function shows the probability of SpringWorks Stock to fall within a particular range of prices over 90 days) .
SpringWorks Therapeutics Price Density |
| Price |
Predictive Modules for SpringWorks Therapeutics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as SpringWorks Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of SpringWorks Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
SpringWorks Therapeutics Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. SpringWorks Therapeutics is not an exception. The market had few large corrections towards the SpringWorks Therapeutics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold SpringWorks Therapeutics, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of SpringWorks Therapeutics within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.02 | |
β | Beta against Dow Jones | 0.42 | |
σ | Overall volatility | 3.67 | |
Ir | Information ratio | -0.0067 |
SpringWorks Therapeutics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of SpringWorks Therapeutics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for SpringWorks Therapeutics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| SpringWorks Therapeutics is not yet fully synchronised with the market data | |
| SpringWorks Therapeutics has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 191.59 M. Net Loss for the year was (258.13 M) with profit before overhead, payroll, taxes, and interest of 204.8 M. | |
| SpringWorks Therapeutics currently holds about 334.54 M in cash with (175.6 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 6.81. | |
| Over 87.0% of the company shares are owned by institutional investors |
SpringWorks Therapeutics Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of SpringWorks Stock often depends not only on the future outlook of the current and potential SpringWorks Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. SpringWorks Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 74.1 M | |
| Cash And Short Term Investments | 308 M |
SpringWorks Therapeutics Fundamentals Growth
SpringWorks Stock prices reflect investors' perceptions of the future prospects and financial health of SpringWorks Therapeutics, and SpringWorks Therapeutics fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on SpringWorks Stock performance.
| Return On Equity | -0.52 | |||
| Return On Asset | -0.28 | |||
| Profit Margin | (1.16) % | |||
| Operating Margin | (1.64) % | |||
| Current Valuation | 3.26 B | |||
| Shares Outstanding | 75.35 M | |||
| Price To Earning | 6.14 X | |||
| Price To Book | 8.49 X | |||
| Price To Sales | 16.12 X | |||
| Revenue | 191.59 M | |||
| EBITDA | (278.13 M) | |||
| Cash And Equivalents | 334.54 M | |||
| Cash Per Share | 6.81 X | |||
| Total Debt | 7.91 M | |||
| Debt To Equity | 0.02 % | |||
| Book Value Per Share | 5.57 X | |||
| Cash Flow From Operations | (175.6 M) | |||
| Earnings Per Share | (3.41) X | |||
| Total Asset | 587.28 M | |||
| Retained Earnings | (1.15 B) | |||
| Current Asset | 29.13 M | |||
| Current Liabilities | 10.16 M | |||
About SpringWorks Therapeutics Performance
Evaluating SpringWorks Therapeutics' performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if SpringWorks Therapeutics has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if SpringWorks Therapeutics has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. SpringWorks Therapeutics, Inc. was founded in 2017 and is headquartered in Stamford, Connecticut. Springworks Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 207 people.Things to note about SpringWorks Therapeutics performance evaluation
Checking the ongoing alerts about SpringWorks Therapeutics for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for SpringWorks Therapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| SpringWorks Therapeutics is not yet fully synchronised with the market data | |
| SpringWorks Therapeutics has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 191.59 M. Net Loss for the year was (258.13 M) with profit before overhead, payroll, taxes, and interest of 204.8 M. | |
| SpringWorks Therapeutics currently holds about 334.54 M in cash with (175.6 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 6.81. | |
| Over 87.0% of the company shares are owned by institutional investors |
- Analyzing SpringWorks Therapeutics' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether SpringWorks Therapeutics' stock is overvalued or undervalued compared to its peers.
- Examining SpringWorks Therapeutics' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating SpringWorks Therapeutics' management team can have a significant impact on its success or failure. Reviewing the track record and experience of SpringWorks Therapeutics' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of SpringWorks Therapeutics' stock. These opinions can provide insight into SpringWorks Therapeutics' potential for growth and whether the stock is currently undervalued or overvalued.
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in poverty. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Other Consideration for investing in SpringWorks Stock
If you are still planning to invest in SpringWorks Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the SpringWorks Therapeutics' history and understand the potential risks before investing.
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data |